FMC CORP (FMC): Results of Operations and Financial Condition
FMC CORP (FMC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FMC Corporation 2929 Walnut Street Philadelphia, PA 19104 USA News Release 215.299.6000 fmc.com For Release: Immediate Media contact: Nicole Canning +1.215.299.5916 Nicole.Canning@fmc.com Investor Contact: Curt Brooks + 1 . 215.299.6137 Curt.Brooks@fmc.com FMC Corpor
How this was made
The 30-second read
Why it matters
The guidance downgrade and large charge estimate introduce near‑term earnings pressure, likely prompting a sell‑off ahead of the upcoming earnings call.
Market read
FMC's updated guidance is material for traders; the stock may experience downside risk before the earnings release.
What to watch
Potential cost reductions from pricing changes and future demand recovery are not quantified in the release.
FMC updates third-quarter expectations to revenue of $65 million to $125 million and Adjusted EBITDA of negative $565 million to negative $510 million following commercial actions expected to create approximately $625 million to $675 million in charges impacting revenue and Adjusted EBITDA.
The preliminary third-quarter outlook calls for very low revenue and negative Adjusted EBITDA, reflecting weaker-than-expected demand, constrained channel product movement, and commercial actions expected to result in approximately $625 million to $675 million in charges impacting revenue and Adjusted EBITDA.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| Third-quarter revenue (expected)GAAP | $65 million to $125 million | – | – |
| Third-quarter revenue excluding India (expected)non-GAAP | $65 million to $125 million | – | – |
| Third-quarter Adjusted EBITDA (expected)non-GAAP | negative $565 million to negative $510 million | – | – |
| Estimated impact related to commercial actions on revenue and Adjusted EBITDAother | approximately $625 million to $675 million | – | – |
third quarter 2026 outlook
- Revenue$65 million to $125 million
- NoteAdjusted EBITDA: negative $565 million to negative $510 million
- NoteCommercial actions are resulting in approximately $625 million to $675 million in charges impacting revenue and Adjusted EBITDA.
What drove it
- Third-quarter demand was weaker than expected.
- Challenging market conditions and elevated levels of higher-priced FMC products held by certain channel customers limited product movement and replenishment demand.
- Rapid market price declines, driven in part by increased generic competition, widened the gap between the value of affected inventory and current market prices.
- FMC is taking commercial actions in Brazil, Argentina, the United States and Canada to lower the price of select products held by channel customers.
- FMC intends to modify its United States selling and pricing model by significantly reducing the gap between gross and net pricing.
- The company expects the actions to accelerate product movement through the channel, support future replenishment demand, improve competitiveness and support channel health.
Concerns
- The company has identified a triggering event to evaluate intangible assets for impairment as of September 30, 2026.
- The impairment assessment was not completed as of the release date, and FMC could be required to record a material non-cash impairment charge during the quarter ending September 30, 2026.
- The company has not finalized its financial results for the quarter and cannot issue or reasonably estimate complete quarterly results in accordance with GAAP as of the release date.
- Channel customers are seeking to operate with the lowest inventory levels FMC has experienced.
- Certain higher-priced FMC products remain in channel inventory under different cost structures, intellectual property positions and competitive conditions.
- FMC intends to discuss potential further covenant modifications with its bank group over the next year.
What to watch
- Third-quarter earnings on October 29, 2026, including finalized GAAP financial results and the company’s 2026 financial outlook.
- FMC’s preliminary expectations for 2027 and 2028, scheduled to be shared on its earnings call on October 30, 2026.
- The outcome and amount, if any, of the intangible-asset impairment assessment.
- Execution of price reductions in Brazil, Argentina, the United States and Canada and modification of the United States selling and pricing model.
- Whether the commercial actions improve channel product movement and future replenishment demand.
- Potential modifications to financial covenants with the company’s bank group.
Balance sheet and cash flow
- The company expects to be in compliance with covenants at September 30, 2026.
- The company intends to engage in discussions with its bank group on potential further modifications to its covenants over the next year to provide greater flexibility.
- Any potential non-cash impairment charge would not have an impact on the Company’s cash flows from current or future operations.
Analysis
FMC issued a preliminary update rather than finalized third-quarter results. The company now expects third-quarter revenue of $65 million to $125 million and Adjusted EBITDA of negative $565 million to negative $510 million. Management attributed weaker-than-expected demand to challenging market conditions and elevated inventories of higher-priced FMC products held by certain channel customers, which limited product movement and replenishment demand.
The update centers on channel inventory economics and pricing. FMC said that rapid market price declines, driven in part by increased generic competition, widened the difference between the value of affected inventory and current market prices. The company is responding by lowering the price of select products held by channel customers in Brazil, Argentina, the United States and Canada, while also changing the United States selling and pricing model to significantly reduce the gap between gross and net pricing.
The commercial actions are expected to result in approximately $625 million to $675 million in charges impacting revenue and Adjusted EBITDA. FMC expects these actions to accelerate movement of products through the channel to growers and support subsequent replenishment demand. The release frames the actions as a broader competitiveness initiative intended to improve channel health and align pricing with current market realities.
Financial-reporting uncertainty remains material. FMC has not finalized third-quarter financial results and said it cannot issue or reasonably estimate complete quarterly results in accordance with GAAP as of the release date. The commercial adjustments and revised outlook also triggered an evaluation of intangible assets for impairment as of September 30, 2026; the assessment was incomplete and could result in a material non-cash impairment charge.
Liquidity and financing flexibility are also areas for attention. FMC expects to be in compliance with covenants at September 30, 2026, but intends to discuss potential further covenant modifications with its bank group over the next year. The company plans to provide third-quarter results and its 2026 financial outlook on October 29, 2026, followed by preliminary expectations for 2027 and 2028 on October 30, 2026.
Management, verbatim
Third-quarter demand was weaker than we expected, driven by challenging market conditions and elevated levels of higher-priced FMC products held in inventory by certain channel customers, which are limiting product movement and replenishment demand.
Pierre Brondeau, chairman, chief executive officer and president
We have addressed this issue incrementally over several quarters, but under current market conditions, we determined that more comprehensive actions are necessary.
Pierre Brondeau, chairman, chief executive officer and president
We believe removing this hurdle is an important step in completing the company's transformation and positioning FMC to operate at its full potential in 2027, 2028 and the long term.
Pierre Brondeau, chairman, chief executive officer and president
Not in the filing
stated, not guessed- Finalized third-quarter 2026 GAAP revenue.
- Finalized third-quarter 2026 revenue excluding India.
- Finalized third-quarter 2026 gross margin.
- Finalized third-quarter 2026 operating expenses.
- Finalized third-quarter 2026 operating income or loss.
- Finalized third-quarter 2026 GAAP net income or loss.
- Finalized third-quarter 2026 GAAP diluted EPS.
- Finalized third-quarter 2026 adjusted earnings or adjusted EPS.
- Finalized third-quarter 2026 operating cash flow.
- Finalized third-quarter 2026 free cash flow.
- Third-quarter 2026 cash balance.
- Third-quarter 2026 debt balance.
- Third-quarter 2026 capital returns, including dividends and share repurchases.
- Segment revenue and segment-level comparisons.
- Prior-year and prior-quarter values for reported metrics.
- Year-over-year and quarter-over-quarter changes for reported metrics.
- Gross margin, operating-expense and tax-rate guidance.
- Final 2026 financial outlook.
- Amount of any potential intangible-asset impairment charge.
- Prior outlook for comparison.
AlphAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
FMC Corp., a global agricultural sciences company, issued an 8‑K filing updating its Q3 outlook and detailing commercial actions to lower product prices in key markets.
Ticker impact
FMC updated its Q3 2026 revenue guidance to $65M‑$125M and announced $625M‑$675M commercial‑action charges, updating outlook.
likely downward pressure as investors price in lower revenue and negative EBITDA
Guidance reduction and sizable charges are material and new, prompting sell pressure ahead of the earnings call.
Market effects
Agricultural chemicals sector may see broader concerns over pricing pressure and inventory issues.
U.S. and North American ag‑chem markets could face margin pressure.
Limited to FMC and peers; no broad market move expected.
Counterpoint
If the commercial actions successfully accelerate product movement, the impact could be short‑lived and the stock may rebound.
Key entities
- ExecutivePierre Brondeau
Chairman, CEO and President of FMC providing the guidance update.
